#takeda — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #takeda, aggregated by home.social.
-
https://www.europesays.com/ie/597660/ What’s at stake as Beijing beats global peers with first approval of novel therapy #CCTV #China #Éire #Europe #Health #IE #Ireland #Japan #NarcolepsyType #NationalMedicalProductsAdministration #NMPA #Takeda #TherapeuticInnovation&RegulatoryScience #US #XuXiaoqiang
-
https://www.europesays.com/ch/105573/ Novartis and Takeda drugs gain rare blood cancer routine use on NHS #Adcetris #BloodCancers #cancer #CancerCells #CancerTherapy #NHSEngland #NHSPatients #Novartis #Tafinlar #Takeda
-
Takeda Pharmaceutical's newly appointed CEO Julie Kim says the company will return to growth in two to three years as it gears up for a wave of product launches. https://www.japantimes.co.jp/business/2026/06/26/companies/takeda-new-ceo/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #us #ai
-
Takeda Pharmaceutical's newly appointed CEO Julie Kim says the company will return to growth in two to three years as it gears up for a wave of product launches. https://www.japantimes.co.jp/business/2026/06/26/companies/takeda-new-ceo/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #us #ai
-
Takeda Pharmaceutical's newly appointed CEO Julie Kim says the company will return to growth in two to three years as it gears up for a wave of product launches. https://www.japantimes.co.jp/business/2026/06/26/companies/takeda-new-ceo/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #us #ai
-
Takeda Pharmaceutical's newly appointed CEO Julie Kim says the company will return to growth in two to three years as it gears up for a wave of product launches. https://www.japantimes.co.jp/business/2026/06/26/companies/takeda-new-ceo/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #us #ai
-
https://www.europesays.com/at/234561/ Pharmakonzern Takeda streicht 200 Jobs in Österreich – vor allem in Wien #aspern #AT #Austria #Gesundheit #Jobs #Österreich #pharma #Seestadt #Stellenabbau #streichen #takeda #Vienna #Wien #Wirtschaft
-
https://www.europesays.com/ch/86909/ Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia #Asia #Astellas #BiotechnologyInnovationOrganization #BoehringerIngelheim #china #Chugai #Eisai #FDA #FiercePharmaAsia #FiercePharmaHomepage #Form483 #GLP1 #InnoventBiologics #KyowaKirin #Lenvima #Leqembi #LicensingDeals #Pharma #Roche #SamsungBioepis #Takeda #WuXiAppTec
-
Ministério da Saúde suspende vacina contra a dengue do Butantan
-
Ministério da Saúde suspende vacina contra a dengue do Butantan
-
A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. https://www.japantimes.co.jp/business/2026/05/19/companies/takeda-antitrust-generic-constipation-drug/?utm_medium=Social&utm_source=mastodon #business #companies #us #medicine #takeda #pharmaceuticals #health
-
A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. https://www.japantimes.co.jp/business/2026/05/19/companies/takeda-antitrust-generic-constipation-drug/?utm_medium=Social&utm_source=mastodon #business #companies #us #medicine #takeda #pharmaceuticals #health
-
A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. https://www.japantimes.co.jp/business/2026/05/19/companies/takeda-antitrust-generic-constipation-drug/?utm_medium=Social&utm_source=mastodon #business #companies #us #medicine #takeda #pharmaceuticals #health
-
A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. https://www.japantimes.co.jp/business/2026/05/19/companies/takeda-antitrust-generic-constipation-drug/?utm_medium=Social&utm_source=mastodon #business #companies #us #medicine #takeda #pharmaceuticals #health
-
https://www.europesays.com/es/488975/ una inversión intergeneracional en salud pública #Anuario2025 #ES #España #Health #Opinión #Salud #Spain #Takeda #Vacunación
-
BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks
🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html
-
BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks
🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html
-
BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks
🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html
-
BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks
🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html
-
BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks
🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html
-
https://www.fogolf.com/1165691/saudi-ladies-rio-takeda-co-leads-after-round-3eyes-on-her-2nd-lpga-title-seasons-first-victory/ Saudi Ladies: Rio Takeda Co-leads after Round 3!Eyes on Her 2nd LPGA Title & Season’s First Victory! #2nd #3Eyes #coleads #GolfLadies #GolfLadyVideos #GolfLadyVlog #GolfLadyYouTube #ladies #LPGA #Rio #Saudi #seasons #Takeda #TITLE #victory
-
https://www.fogolf.com/1165691/saudi-ladies-rio-takeda-co-leads-after-round-3eyes-on-her-2nd-lpga-title-seasons-first-victory/ Saudi Ladies: Rio Takeda Co-leads after Round 3!Eyes on Her 2nd LPGA Title & Season’s First Victory! #2nd #3Eyes #coleads #GolfLadies #GolfLadyVideos #GolfLadyVlog #GolfLadyYouTube #ladies #LPGA #Rio #Saudi #seasons #Takeda #TITLE #victory
-
https://www.fogolf.com/1165576/rio-takeda-eagle-hole-12-par-5-round-3-pif-saudi-ladies-international-2026-golf-let-riotakeda/ Rio Takeda: Eagle Hole 12 Par 5 Round 3 PIF Saudi Ladies International 2026 #golf #let #riotakeda #eagle #Golf #GolfLadies #GolfLadyVideos #GolfLadyVlog #GolfLadyYouTube #hole #International #ladies #Par #PIF #Rio #riotakeda #Saudi #Takeda
-
https://www.fogolf.com/1165576/rio-takeda-eagle-hole-12-par-5-round-3-pif-saudi-ladies-international-2026-golf-let-riotakeda/ Rio Takeda: Eagle Hole 12 Par 5 Round 3 PIF Saudi Ladies International 2026 #golf #let #riotakeda #eagle #Golf #GolfLadies #GolfLadyVideos #GolfLadyVlog #GolfLadyYouTube #hole #International #ladies #Par #PIF #Rio #riotakeda #Saudi #Takeda
-
https://www.alojapan.com/1449615/takeda-kyoto-university-end-10-year-stem-cell-tie-up-with-no-new-drugs/ Takeda, Kyoto University end 10-year stem cell tie-up, with no new drugs #10Year #cell #drugs #end #Kyoto #KyotoNews #new #news #no #STEM #takeda #TieUp #university #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Japan’s Tak
-
https://www.alojapan.com/1449615/takeda-kyoto-university-end-10-year-stem-cell-tie-up-with-no-new-drugs/ Takeda, Kyoto University end 10-year stem cell tie-up, with no new drugs #10Year #cell #drugs #end #Kyoto #KyotoNews #new #news #no #STEM #takeda #TieUp #university #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Japan’s Tak
-
Takeda, Kyoto University end fruitless stem cell drug search after 10 years
Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO …
#Japan #JP #Kyoto #10 #cell #drug #end #fruitless #kyotonews #news #search #STEM #takeda #university #year's #京都 #京都府
https://www.alojapan.com/1449583/takeda-kyoto-university-end-fruitless-stem-cell-drug-search-after-10-years/ -
Takeda, Kyoto University end fruitless stem cell drug search after 10 years
Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO …
#Japan #JP #Kyoto #10 #cell #drug #end #fruitless #kyotonews #news #search #STEM #takeda #university #year's #京都 #京都府
https://www.alojapan.com/1449583/takeda-kyoto-university-end-fruitless-stem-cell-drug-search-after-10-years/ -
https://www.alojapan.com/1449583/takeda-kyoto-university-end-fruitless-stem-cell-drug-search-after-10-years/ Takeda, Kyoto University end fruitless stem cell drug search after 10 years #10 #cell #drug #end #fruitless #Kyoto #KyotoNews #news #search #STEM #takeda #university #year's #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Ja
-
https://www.alojapan.com/1449583/takeda-kyoto-university-end-fruitless-stem-cell-drug-search-after-10-years/ Takeda, Kyoto University end fruitless stem cell drug search after 10 years #10 #cell #drug #end #fruitless #Kyoto #KyotoNews #news #search #STEM #takeda #university #year's #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Ja
-
https://www.europesays.com/es/306876/ Takeda anuncia resultados positivos de zasocitinib en adultos con psoriasis en placas de moderada a grave #B1 #Business #dermatología #Economía #Economy #ES #España #Investigación #Medicamentos #Psoriasis #Spain #Takeda
-
Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. https://www.japantimes.co.jp/news/2025/12/18/japan/takeda-psoriasis-pill-ai/?utm_medium=Social&utm_source=mastodon #japan #medicine #ai #takeda
-
Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. https://www.japantimes.co.jp/news/2025/12/18/japan/takeda-psoriasis-pill-ai/?utm_medium=Social&utm_source=mastodon #japan #medicine #ai #takeda
-
Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. https://www.japantimes.co.jp/news/2025/12/18/japan/takeda-psoriasis-pill-ai/?utm_medium=Social&utm_source=mastodon #japan #medicine #ai #takeda
-
Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. https://www.japantimes.co.jp/news/2025/12/18/japan/takeda-psoriasis-pill-ai/?utm_medium=Social&utm_source=mastodon #japan #medicine #ai #takeda
-
Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations
-
Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations
-
Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations
-
Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations
-
https://www.europesays.com/es/216776/ El reto del linfoma de Hodgkin en mayores; los expertos reclaman un abordaje multidisciplinar #Andalucía #Comorbilidad #EncuentroDeExpertos #ES #España #Geriatría #Health #Inmunología #Investigación #InvestigaciónDesarrolloEInnovación(I+D+i) #linfoma #Oncología #prevención #quimioterapia #Salud #Spain #Takeda #tolerancia
-
タケダのワクチンへの取り組み 新型コロナワクチンの情報は「コロナ情報館」｜武田薬品工業株式会社【公式】 https://www.yayafa.com/2568162/ #biopharmaceutical #business #Future #global #Health #Introduction #Medicine #Mission #People #pharmaceutical #Philosophy #Rd #Takeda #TakedaIsm #values #Vision #新型コロナウイルスで
-
タケダのワクチンへの取り組み 新型コロナワクチンの情報は「コロナ情報館」｜武田薬品工業株式会社【公式】 https://www.yayafa.com/2568162/ #biopharmaceutical #business #Future #global #Health #Introduction #Medicine #Mission #People #pharmaceutical #Philosophy #Rd #Takeda #TakedaIsm #values #Vision #新型コロナウイルスで
-
タケダのワクチンへの取り組み 新型コロナワクチンの情報は「コロナ情報館」｜武田薬品工業株式会社【公式】 https://www.yayafa.com/2568162/ #biopharmaceutical #business #Future #global #Health #Introduction #Medicine #Mission #People #pharmaceutical #Philosophy #Rd #Takeda #TakedaIsm #values #Vision #新型コロナウイルスで
-
Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep
-
Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep
-
Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep
-
Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings